This report contains market size and forecasts of Measles and Rubella Vaccines in global, including the following market information:
Global Measles and Rubella Vaccines Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Measles and Rubella Vaccines Market Sales, 2018-2023, 2023-2030, (K Doses)
Global top five Measles and Rubella Vaccines companies in 2022 (%)
The global Measles and Rubella Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Monovalent Vaccines Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Measles and Rubella Vaccines include Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Measles and Rubella Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles and Rubella Vaccines Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Doses)
Global Measles and Rubella Vaccines Market Segment Percentages, by Type, 2022 (%)
Monovalent Vaccines
Multivalent Vaccines
Global Measles and Rubella Vaccines Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Doses)
Global Measles and Rubella Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Measles and Rubella Vaccines Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Doses)
Global Measles and Rubella Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measles and Rubella Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Measles and Rubella Vaccines revenues share in global market, 2022 (%)
Key companies Measles and Rubella Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Measles and Rubella Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Measles and Rubella Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles and Rubella Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Measles and Rubella Vaccines Overall Market Size
2.1 Global Measles and Rubella Vaccines Market Size: 2022 VS 2030
2.2 Global Measles and Rubella Vaccines Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Measles and Rubella Vaccines Sales: 2018-2030
3 Company Landscape
3.1 Top Measles and Rubella Vaccines Players in Global Market
3.2 Top Global Measles and Rubella Vaccines Companies Ranked by Revenue
3.3 Global Measles and Rubella Vaccines Revenue by Companies
3.4 Global Measles and Rubella Vaccines Sales by Companies
3.5 Global Measles and Rubella Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Measles and Rubella Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Measles and Rubella Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles and Rubella Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Measles and Rubella Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles and Rubella Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Measles and Rubella Vaccines Market Size Markets, 2022 & 2030
4.1.2 Monovalent Vaccines
4.1.3 Multivalent Vaccines
4.2 By Type - Global Measles and Rubella Vaccines Revenue & Forecasts
4.2.1 By Type - Global Measles and Rubella Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Measles and Rubella Vaccines Revenue, 2023-2030
4.2.3 By Type - Global Measles and Rubella Vaccines Revenue Market Share, 2018-2030
4.3 By Type - Global Measles and Rubella Vaccines Sales & Forecasts
4.3.1 By Type - Global Measles and Rubella Vaccines Sales, 2018-2023
4.3.2 By Type - Global Measles and Rubella Vaccines Sales, 2023-2030
4.3.3 By Type - Global Measles and Rubella Vaccines Sales Market Share, 2018-2030
4.4 By Type - Global Measles and Rubella Vaccines Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Measles and Rubella Vaccines Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Measles and Rubella Vaccines Revenue & Forecasts
5.2.1 By Application - Global Measles and Rubella Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Measles and Rubella Vaccines Revenue, 2023-2030
5.2.3 By Application - Global Measles and Rubella Vaccines Revenue Market Share, 2018-2030
5.3 By Application - Global Measles and Rubella Vaccines Sales & Forecasts
5.3.1 By Application - Global Measles and Rubella Vaccines Sales, 2018-2023
5.3.2 By Application - Global Measles and Rubella Vaccines Sales, 2023-2030
5.3.3 By Application - Global Measles and Rubella Vaccines Sales Market Share, 2018-2030
5.4 By Application - Global Measles and Rubella Vaccines Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Measles and Rubella Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Measles and Rubella Vaccines Revenue & Forecasts
6.2.1 By Region - Global Measles and Rubella Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Measles and Rubella Vaccines Revenue, 2023-2030
6.2.3 By Region - Global Measles and Rubella Vaccines Revenue Market Share, 2018-2030
6.3 By Region - Global Measles and Rubella Vaccines Sales & Forecasts
6.3.1 By Region - Global Measles and Rubella Vaccines Sales, 2018-2023
6.3.2 By Region - Global Measles and Rubella Vaccines Sales, 2023-2030
6.3.3 By Region - Global Measles and Rubella Vaccines Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Measles and Rubella Vaccines Revenue, 2018-2030
6.4.2 By Country - North America Measles and Rubella Vaccines Sales, 2018-2030
6.4.3 US Measles and Rubella Vaccines Market Size, 2018-2030
6.4.4 Canada Measles and Rubella Vaccines Market Size, 2018-2030
6.4.5 Mexico Measles and Rubella Vaccines Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Measles and Rubella Vaccines Revenue, 2018-2030
6.5.2 By Country - Europe Measles and Rubella Vaccines Sales, 2018-2030
6.5.3 Germany Measles and Rubella Vaccines Market Size, 2018-2030
6.5.4 France Measles and Rubella Vaccines Market Size, 2018-2030
6.5.5 U.K. Measles and Rubella Vaccines Market Size, 2018-2030
6.5.6 Italy Measles and Rubella Vaccines Market Size, 2018-2030
6.5.7 Russia Measles and Rubella Vaccines Market Size, 2018-2030
6.5.8 Nordic Countries Measles and Rubella Vaccines Market Size, 2018-2030
6.5.9 Benelux Measles and Rubella Vaccines Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Measles and Rubella Vaccines Revenue, 2018-2030
6.6.2 By Region - Asia Measles and Rubella Vaccines Sales, 2018-2030
6.6.3 China Measles and Rubella Vaccines Market Size, 2018-2030
6.6.4 Japan Measles and Rubella Vaccines Market Size, 2018-2030
6.6.5 South Korea Measles and Rubella Vaccines Market Size, 2018-2030
6.6.6 Southeast Asia Measles and Rubella Vaccines Market Size, 2018-2030
6.6.7 India Measles and Rubella Vaccines Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Measles and Rubella Vaccines Revenue, 2018-2030
6.7.2 By Country - South America Measles and Rubella Vaccines Sales, 2018-2030
6.7.3 Brazil Measles and Rubella Vaccines Market Size, 2018-2030
6.7.4 Argentina Measles and Rubella Vaccines Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Measles and Rubella Vaccines Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Measles and Rubella Vaccines Sales, 2018-2030
6.8.3 Turkey Measles and Rubella Vaccines Market Size, 2018-2030
6.8.4 Israel Measles and Rubella Vaccines Market Size, 2018-2030
6.8.5 Saudi Arabia Measles and Rubella Vaccines Market Size, 2018-2030
6.8.6 UAE Measles and Rubella Vaccines Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Serum Institute of India Ltd.
7.1.1 Serum Institute of India Ltd. Corporate Summary
7.1.2 Serum Institute of India Ltd. Business Overview
7.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Major Product Offerings
7.1.4 Serum Institute of India Ltd. Measles and Rubella Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Serum Institute of India Ltd. Key News
7.2 Merck & Co. Inc.
7.2.1 Merck & Co. Inc. Corporate Summary
7.2.2 Merck & Co. Inc. Business Overview
7.2.3 Merck & Co. Inc. Measles and Rubella Vaccines Major Product Offerings
7.2.4 Merck & Co. Inc. Measles and Rubella Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co. Inc. Key News
7.3 GlaxoSmithKline Inc.
7.3.1 GlaxoSmithKline Inc. Corporate Summary
7.3.2 GlaxoSmithKline Inc. Business Overview
7.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Major Product Offerings
7.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Inc. Key News
7.4 Takeda Pharmaceutical Company
7.4.1 Takeda Pharmaceutical Company Corporate Summary
7.4.2 Takeda Pharmaceutical Company Business Overview
7.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Major Product Offerings
7.4.4 Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Takeda Pharmaceutical Company Key News
8 Global Measles and Rubella Vaccines Production Capacity, Analysis
8.1 Global Measles and Rubella Vaccines Production Capacity, 2018-2030
8.2 Measles and Rubella Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles and Rubella Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Measles and Rubella Vaccines Supply Chain Analysis
10.1 Measles and Rubella Vaccines Industry Value Chain
10.2 Measles and Rubella Vaccines Upstream Market
10.3 Measles and Rubella Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles and Rubella Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Measles and Rubella Vaccines in Global Market
Table 2. Top Measles and Rubella Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Measles and Rubella Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Measles and Rubella Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Measles and Rubella Vaccines Sales by Companies, (K Doses), 2018-2023
Table 6. Global Measles and Rubella Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Measles and Rubella Vaccines Price (2018-2023) & (US$/Dose)
Table 8. Global Manufacturers Measles and Rubella Vaccines Product Type
Table 9. List of Global Tier 1 Measles and Rubella Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Measles and Rubella Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Measles and Rubella Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Measles and Rubella Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Measles and Rubella Vaccines Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Measles and Rubella Vaccines Sales (K Doses), 2018-2023
Table 15. By Type - Global Measles and Rubella Vaccines Sales (K Doses), 2023-2030
Table 16. By Application ? Global Measles and Rubella Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Measles and Rubella Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Measles and Rubella Vaccines Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Measles and Rubella Vaccines Sales (K Doses), 2018-2023
Table 20. By Application - Global Measles and Rubella Vaccines Sales (K Doses), 2023-2030
Table 21. By Region ? Global Measles and Rubella Vaccines Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Measles and Rubella Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Measles and Rubella Vaccines Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Measles and Rubella Vaccines Sales (K Doses), 2018-2023
Table 25. By Region - Global Measles and Rubella Vaccines Sales (K Doses), 2023-2030
Table 26. By Country - North America Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Measles and Rubella Vaccines Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Measles and Rubella Vaccines Sales, (K Doses), 2018-2023
Table 29. By Country - North America Measles and Rubella Vaccines Sales, (K Doses), 2023-2030
Table 30. By Country - Europe Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Measles and Rubella Vaccines Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Measles and Rubella Vaccines Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Measles and Rubella Vaccines Sales, (K Doses), 2023-2030
Table 34. By Region - Asia Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Measles and Rubella Vaccines Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Measles and Rubella Vaccines Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Measles and Rubella Vaccines Sales, (K Doses), 2023-2030
Table 38. By Country - South America Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Measles and Rubella Vaccines Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Measles and Rubella Vaccines Sales, (K Doses), 2018-2023
Table 41. By Country - South America Measles and Rubella Vaccines Sales, (K Doses), 2023-2030
Table 42. By Country - Middle East & Africa Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Measles and Rubella Vaccines Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Measles and Rubella Vaccines Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Measles and Rubella Vaccines Sales, (K Doses), 2023-2030
Table 46. Serum Institute of India Ltd. Corporate Summary
Table 47. Serum Institute of India Ltd. Measles and Rubella Vaccines Product Offerings
Table 48. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 49. Merck & Co. Inc. Corporate Summary
Table 50. Merck & Co. Inc. Measles and Rubella Vaccines Product Offerings
Table 51. Merck & Co. Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 52. GlaxoSmithKline Inc. Corporate Summary
Table 53. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Offerings
Table 54. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 55. Takeda Pharmaceutical Company Corporate Summary
Table 56. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Offerings
Table 57. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 58. Measles and Rubella Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 59. Global Measles and Rubella Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Measles and Rubella Vaccines Production by Region, 2018-2023 (K Doses)
Table 61. Global Measles and Rubella Vaccines Production by Region, 2023-2030 (K Doses)
Table 62. Measles and Rubella Vaccines Market Opportunities & Trends in Global Market
Table 63. Measles and Rubella Vaccines Market Drivers in Global Market
Table 64. Measles and Rubella Vaccines Market Restraints in Global Market
Table 65. Measles and Rubella Vaccines Raw Materials
Table 66. Measles and Rubella Vaccines Raw Materials Suppliers in Global Market
Table 67. Typical Measles and Rubella Vaccines Downstream
Table 68. Measles and Rubella Vaccines Downstream Clients in Global Market
Table 69. Measles and Rubella Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Measles and Rubella Vaccines Segment by Type
Figure 2. Measles and Rubella Vaccines Segment by Application
Figure 3. Global Measles and Rubella Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Measles and Rubella Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Measles and Rubella Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. Measles and Rubella Vaccines Sales in Global Market: 2018-2030 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Measles and Rubella Vaccines Revenue in 2022
Figure 9. By Type - Global Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 10. By Type - Global Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 11. By Type - Global Measles and Rubella Vaccines Price (US$/Dose), 2018-2030
Figure 12. By Application - Global Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 13. By Application - Global Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 14. By Application - Global Measles and Rubella Vaccines Price (US$/Dose), 2018-2030
Figure 15. By Region - Global Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 16. By Region - Global Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 17. By Country - North America Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 18. By Country - North America Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 19. US Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 24. Germany Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. France Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 33. China Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 37. India Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 39. By Country - South America Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 40. Brazil Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Measles and Rubella Vaccines Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Measles and Rubella Vaccines Sales Market Share, 2018-2030
Figure 44. Turkey Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Measles and Rubella Vaccines Revenue, (US$, Mn), 2018-2030
Figure 48. Global Measles and Rubella Vaccines Production Capacity (K Doses), 2018-2030
Figure 49. The Percentage of Production Measles and Rubella Vaccines by Region, 2022 VS 2030
Figure 50. Measles and Rubella Vaccines Industry Value Chain
Figure 51. Marketing Channels
